Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2009, Vol. 29 Issue (10): 28-32    DOI:
    
Optimization of Expression by Response Surface Methodology and Purification of Recombinant Human Cardiac TroponinI(cTnI) in Escherichia coli
YANG Lei,ZHANG Chun-ming,WANG De-zhi
Tianjin Key Laboratory of Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China
Download: HTML   PDF(423KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

To optimize the growth condition for the established gene engineer bacteria express cardiac troponin-I( cTnI) and to obtain purified cTnI as an antigen to produce clinical assay kits used in acute myocardial injury(AMI) diagnosis. Plackett Burman Design (PBD) was applied to select the factors which effect the expression of cTnI in Escherichial coli(E.coli) mostly. Induction time, pH and KCl were proved influenced expression of cTnI notably. Afterward, Response Surface Methodology (RSM) as second step to optimize the selected three factors, an equation was deduced to predict the percent of cTnI. In the most optimized condition, the percent of cTnI can reach to 26% of total cell protein. The procedures of purification included ammonium sulfate deposition and DEAE Cellulose ion exchange chromatography. SDSPAGE shows that purified cTnI contain one band. cTnI could be used to immune animals as an antigen to produce monoclonal antibodies with high affinity and specificity. It maybe as calibrators to harmony the difference assays of cTnI measurement in clinical.



Key wordsCardiac troponin I (cTnI)      Response Surface Methodology (RSM)      Ion-exchange Chromatography     
Received: 21 May 2009      Published: 29 October 2009
ZTFLH:  Q786  
Cite this article:

YANG Lei, ZHANG Chun-Meng, WANG De-Zhi. Optimization of Expression by Response Surface Methodology and Purification of Recombinant Human Cardiac TroponinI(cTnI) in Escherichia coli. China Biotechnology, 2009, 29(10): 28-32.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2009/V29/I10/28

[1] PEI Zheng-pei, LI Bo, ZHANG Wei, GAO Hong-liang, CHANG Zhong-yi, JIN Ming-fei, LU Wei, BU Guo-jian. Large Scale Purification of Pharmaceutical Grade Microbial Transglutaminase from Streptoverticillium mobaraense[J]. China Biotechnology, 2014, 34(4): 53-58.
[2] Chunping Cui Dajin ZHANG . Construction, expression and Purification of a Novel Human Hepatic Growth Factor: Hepatopoietin Cn and Research on its Biological Activity in vitro[J]. China Biotechnology, 2007, 27(10): 6-11.